Missouri reactor aims to produce "moly 99" in 4 years

04/5/2009 | St. Louis Post-Dispatch

The University of Missouri Research Reactor next year plans to file a license application with the Nuclear Regulatory Commission to produce molybdenum 99 -- the source isotope of technetium 99m used in nuclear medicine. The research reactor is aiming to supply about 50% of the country's demand for "moly 99" using low-enriched uranium within the next four years.

View Full Article in:

St. Louis Post-Dispatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY